Scientific Programme Highlights

› ESGO Congress: A Global Stage of Gynaecological Oncology Best Practice and Research

8R1A8187

The ESGO 2023 Congress kicks off with an exciting 4-day programme on September 28, 2023.

This year's congress will highlight the latest clinical and scientific developments in gynaecological cancers, with more than 50 scientific sessions delivered by renowned international experts focusing on a variety of topics driving research, treatment and care forward.

Don't miss the very best of gynaecological oncology practice and research, latest findings, practical take-home messages and a wealth of knowledge for your daily practice.

Join us in Istanbul for ESGO 2023, the largest gathering in the field of gynaecological oncology!

› ESGO 2023 Programme: More Opportunities to Advance Your Knowledge

DSC_6466
  • Live surgery performed from hospitals of recognized prestige where you can assess different surgical perspectives.
  • Exclusive State of the Art Sessions in the treatment of gynaecological tumours following the ESGO clinical guidelines
  • Debates Sessions on hot controversial topics
  • Practice-changing Trials in 2023: update on the scientific advances in the results of the latest clinical trials that are changing daily practice.
  • Current options for sparing fertility treatment
  • Latest advances in chemotherapy, radiotherapy, and immunotherapy
  • New Emerging Pathways and Targeted Treatments in gynaecological cancers
  • Most recent translational research, including biomarkers, liquid biopsies, and antibody-drug conjugates.
  • Video Sessions of the latest Surgical and Imaging Techniques
  • Tumour Board Sessions
  • Oral Presentations of the best abstracts
  • ENYGO Programme designed for young gynaecological oncologists
  • 2-day Patient Advocacy Seminar organised by ENGAGe

and much more...

Topics will include the newest aspects in (molecular) diagnostics, surgical, radiotherapeutic and medical concepts, as well as tailored strategies at the time of diagnosis and recurrent disease.

Surgical approaches have been subjected to changes and individualisation, based on both tumour characteristics and patients’ needs.

Improved knowledge about tumour biology and the implementation of new biomarkers has led to new trends of personalised medicine and the selection of patients for individualised treatment.

8R1A7905

Interested to find out more? The ESGO 2023 programme, searchable by speaker and topics, will be available soon.

You may also like

ESGO_2015_24102015_0296_WEB

Reasons to Attend

ESGO 2019 webcasts

ESGO 2023

Scientific Programme Highlights

 

Explore it Now!

speakers1

Photo Gallery

Great moments from ESGO 2022!

 

View it Now!

register

Registration

Regular rates end on Sept 10!

 

Register Now!